Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,216.00    38.00 (1.74%)
Bid:
2,220.00
Ask:
2,228.00
Spread: 8.00 (0.36%)
Market Cap: £1.47b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

17 Sep 2025 12:14

RNS Number : 7359Z
Genus PLC
17 September 2025
 

17 September 2025

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that, further to the vesting on 14 September 2025 of conditional nil-cost options granted in 2022 under the Genus 2019 Performance Share Plan (the 'PSP'), as listed in tables A and B below; and conditional nil-cost options granted in 2022 under the Genus Deferred Share Bonus Plan (the 'DSBP') as listed in tables C and D below, members of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus on 15 September 2025 and 16 September 2025 on the London Stock Exchange, to offset income tax and social security liabilities due on the exercises and retained the following balances of ordinary shares:

 

PDMR Name

PSP Nil-Cost Options

(Tables A and B)

DSBP

(Tables C and D)

Exercised

Sold to offset taxes due on exercise

Retained net of tax

Exercised

Sold to offset taxes due on exercise

Retained net of tax

Matt Culbertson*

a. 1,637

b. 3,961

a. 477

b. 1,154

a. 1,160

b. 2,807

526

153

373

Elena Rice

6,376

2,727

3,649

231

99

132

Jerry Thompson

6,254

2,993

3,261

1,111

532

579

Angelle Rosata

5,760

2,308

3,452

419

168

251

* Matt Culbertson was granted PSP nil-cost options in September 2022 as part of the annual grant cycle and in December 2022 on his appointment to GELT.

 

Conditional nil-cost options granted under the PSP were subject to relevant performance conditions, measured over a three-year performance period which commenced on 1 July 2022 and ended on 30 June 2025. Following assessment of the performance conditions, the Remuneration Committee determined that the proportion of awards to which performance conditions applied would vest at 20% of the original grant and the balance of awards have lapsed.

 

Genus also announces that, further to the vesting on 14 September 2025 of conditional share awards granted in 2022 under the Genus 2019 Performance Share Plan (the 'PSP'), as listed in table E below, Matt Culbertson and Mark Birri, members of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus on 16 September 2025 on the London Stock Exchange, to offset income tax and social security liabilities due on the releases and retained the following balances of ordinary shares:

 

PDMR Name

PSP Share Awards (Table E)

Exercised

Sold to offset taxes due on exercise

Retained net of tax

Matt Culbertson

a. 3,508

b. 584

a. 1,007

b. 167

a. 2501

b. 417

Mark Birri

a. 1,057

b. 264

a. 499

b. 124

a. 558

b. 140

 

 

Conditional share awards were granted to Matt Culbertson and Mark Birri under the PSP prior to them becoming members of GELT. These conditional share awards were not subject to company performance conditions.

 

The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail on the number of nil-cost options exercised and ordinary shares sold on 15 September 2025 and 16 September 2025.

 

For further information please contact:

 

Genus:

Vaughn Walton, Deputy Company Secretary Tel: +44 (0)1256 347100

 

 

 

Table A - GELT 2019 Performance Share Plan Exercise

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Angelle Rosata

2.

Reason for the notification

a.

Position/status

Group Human Resources Director

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of nil-cost options under the PSP.

c.

Price(s) and volume(s)

 

Price(s)

Volume(s)

0p

5,760

d.

Aggregated information

· Aggregated volume

· Price

 

Price(s)

Volume(s)

0p

5,760

 

 

 

e.

Date of the transaction

2025-09-15

f.

Place of the transaction

Outside a trading venue.

5.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Sale of shares arising from the exercise of nil-cost options under the PSP to offset income tax and social security liabilities due on the exercise.

c.

Price(s) and volume(s)

 

Price(s)

Volume(s)

2,545p

2,308

d.

Aggregated information

· Aggregated volume

· Price

 

 

Price(s)

Volume(s)

2,545p

2,308

e.

Date of the transaction

2025-09-15

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

Table B - GELT 2019 Performance Share Plan Exercise

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Matt Culbertson

2. Elena Rice

3. Jerry Thompson

2.

Reason for the notification

a.

Position/status

1. Chief Operating Officer Genus PIC

2. Chief Scientific Officer

3. Regional Director of ABS EMEA

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of nil-cost options under the PSP.

c.

Price(s) and volume(s)

Numbers 1 to 3 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

Volume(s)

1a. 0p

1,637

1b. 0p

3,961

2. 0p

6,376

3. 0p

6,254

d.

Aggregated information

· Aggregated volume

· Price

 

Price(s)

Volume(s)

1a. 0p

1,637

1b. 0p

3,961

2. 0p

6,376

3. 0p

6,254

Numbers 1 to 3 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

 

 

e.

Date of the transaction

2025-09-16

f.

Place of the transaction

Outside a trading venue.

5.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Sale of shares arising from the exercise of nil-cost options under the PSP to offset income tax and social security liabilities due on the exercise.

c.

Price(s) and volume(s)

Numbers 1 to 3 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

Volume(s)

1a. 2,577p

477

1b. 2,577p

1,154

2. 2,555p

2,727

3. 2,567p

2,993

d.

Aggregated information

· Aggregated volume

· Price

 

Numbers 1 to 3 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

Volume(s)

1a. 2,577p

477

1b. 2,577p

1,154

2. 2,555p

2,727

3. 2,567p

2,993

e.

Date of the transaction

2025-09-16

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

Table C - GELT Deferred Share Bonus Plan Exercise

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Angelle Rosata

2.

Reason for the notification

a.

Position/status

Group Human Resources Director

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of nil-cost options under the DSBP.

c.

Price(s) and volume(s)

 

Price(s)

Volume(s)

0p

419

d.

Aggregated information

· Aggregated volume

· Price

 

Price(s)

Volume(s)

0p

419

 

 

 

 

 

 

 

 

 

e.

Date of the transaction

2025-09-15

f.

Place of the transaction

Outside a trading venue.

5.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Sale of shares arising from the exercise of nil-cost options under the DSBP to offset income tax and social security liabilities due on the exercise.

c.

Price(s) and volume(s)

 

Price(s)

Volume(s)

2,545p

168

d.

Aggregated information

· Aggregated volume

· Price

 

 

Price(s)

Volume(s)

2,545p

168

e.

Date of the transaction

2025-09-15

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

Table D - GELT Deferred Share Bonus Plan Exercise

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Matt Culbertson

2. Elena Rice

3. Jerry Thompson

2.

Reason for the notification

a.

Position/status

1. Chief Operating Officer Genus PIC

2. Chief Scientific Officer

3. Regional Director of ABS EMEA

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of nil-cost options under the DSBP.

c.

Price(s) and volume(s)

Numbers 1 to 3 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

Volume(s)

1. 0p

526

2. 0p

231

3. 0p

1,111

d.

Aggregated information

· Aggregated volume

· Price

 

Price(s)

Volume(s)

1. 0p

526

2. 0p

231

3. 0p

1,111

Numbers 1 to 3 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

 

 

 

 

 

 

 

 

e.

Date of the transaction

2025-09-16

f.

Place of the transaction

Outside a trading venue.

5.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Sale of shares arising from the exercise of nil-cost options under the DSBP to offset income tax and social security liabilities due on the exercise.

c.

Price(s) and volume(s)

Numbers 1 to 3 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

Volume(s)

1. 2,577p

153

2. 2,555p

99

3. 2,567p

532

d.

Aggregated information

· Aggregated volume

· Price

 

Numbers 1 to 3 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

Volume(s)

1. 2,577p

153

2. 2,555p

99

3. 2,567p

532

e.

Date of the transaction

2025-09-16

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

 

Table E - GELT 2019 Performance Share Plan Release

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Matt Culbertson

2. Mark Birri

2.

Reason for the notification

b.

Position/status

1. Chief Operating Officer Genus PIC

2. Chief Corporate Development Officer

c.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

d.

Name

Genus plc

e.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

f.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

g.

Nature of the transaction

Release of conditional share awards under the PSP.

h.

Price(s) and volume(s)

Numbers 1 and 2 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

Volume(s)

1a. 0p

3,508

1b. 0p

584

2a. 0p

1,057

2b. 0p

264

i.

Aggregated information

· Aggregated volume

· Price

 

Numbers 1 and 2 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

Volume(s)

1a. 0p

3,508

1b. 0p

584

2a. 0p

1,057

2b. 0p

264

j.

Date of the transaction

2025-09-16

k.

Place of the transaction

Outside a trading venue.

5.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Sale of shares arising from the release of conditional share awards under the PSP to offset income tax and social security liabilities due on the release.

c.

Price(s) and volume(s)

Numbers 1 and 2 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

Volume(s)

1a. 2,562p

1007

1b. 2,562p

167

2a. 2,562p

499

2b. 2,562p

124

d.

Aggregated information

· Aggregated volume

· Price

 

Numbers 1 and 2 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

Volume(s)

1a. 2,562p

1007

1b. 2,562p

167

2a. 2,562p

499

2b. 2,562p

124

e.

Date of the transaction

2025-09-16

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUBAARVUUKAAR
Date   Source Headline
16th Jun 20268:28 amRNSHolding(s) in Company
13th May 202612:32 pmRNSDirector/PDMR Shareholding
1st May 20269:20 amRNSTotal Voting Rights
13th Apr 20265:59 pmRNSDirector/PDMR Shareholding
1st Apr 20269:40 amRNSDirector/PDMR Shareholding
10th Mar 20263:56 pmRNSNotification of Major Holdings
10th Mar 20263:56 pmRNSNotification of Major Holdings
4th Mar 202610:33 amRNSDirector/PDMR Shareholding
4th Mar 202610:08 amRNSDirector Declaration
27th Feb 202612:48 pmRNSDirector/PDMR Shareholding
26th Feb 20267:00 amRNSInterim Results
2nd Feb 202612:39 pmRNSBlock Listing Return
2nd Feb 202611:21 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSSuccessful formation of Chinese porcine JV
23rd Jan 20265:23 pmRNSPRP Regulatory Progress – Canada
16th Jan 20267:00 amRNSHalf Year Trading Update – Ahead of expectations
27th Nov 20257:00 amRNSDirector/PDMR Shareholding
19th Nov 202512:12 pmRNSResults of AGM
19th Nov 20257:00 amRNSNon-Executive Director Appointments
19th Nov 20257:00 amRNSAGM Trading Update
3rd Nov 202510:56 amRNSTotal Voting Rights
14th Oct 20254:02 pmRNSNotification of Major Holdings
10th Oct 20257:00 amRNSNotice of AGM
1st Oct 20259:47 amRNSTotal Voting Rights
25th Sep 20254:49 pmRNSDirector/PDMR Shareholding
24th Sep 202511:35 amRNSDirector/PDMR Shareholding
19th Sep 20252:39 pmRNSDirector/PDMR Shareholding
17th Sep 202512:14 pmRNSDirector/PDMR Shareholding
11th Sep 202512:20 pmRNSDirector/PDMR Shareholding
8th Sep 20254:05 pmRNSAdditional Listing
4th Sep 20257:00 amRNSPreliminary results
4th Sep 20257:00 amRNSAccelerated Chinese porcine JV formation
28th Aug 20254:57 pmRNSNotification of Major Holdings
19th Aug 20253:03 pmRNSNotification of Major Holdings
19th Aug 20257:00 amRNSNotification of Major Holdings
6th Aug 202510:51 amBUSHolding(s) in Company
4th Aug 202511:14 amRNSNotification of Major Holdings
1st Aug 202510:10 amRNSBlock Listing Six Monthly Return
1st Aug 202510:05 amRNSTotal Voting Rights
15th Jul 20257:00 amRNSFY25 Trading Update
9th May 20259:25 amRNSAppointment of Financial Adviser & joint Broker
1st May 20252:28 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNSPRRS Resistant Pig – FDA Approval
25th Apr 20254:30 pmRNSNotification of Major Holdings
25th Apr 20254:28 pmRNSNotification of Major Holdings
2nd Apr 20255:08 pmRNSDirector/PDMR Shareholding
2nd Apr 20253:43 pmRNSNotification of Major Holdings
13th Mar 20257:00 amRNSAppointment of Chief Financial Officer Designate
3rd Mar 202511:32 amRNSTotal Voting Rights
28th Feb 20251:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.